Some brands of nationalism can be injurious to your health!

Dinesh Thakur goes to court over medicine quality; drug controller wants whistleblowers to be nationalistic!

GN Bureau | March 8, 2016


#CDSCO   #Ranbaxy   #whistleblowers   #medicine quality   #Dinesh Thakur  


The next battle over ‘nationalism’ is beginning: apparently, if you criticise the dangerous state of drug manufacturing in India that can kill people, you might not be nationalistic.

Dinesh Thakur exposed Ranbaxy’s practices in the US, and the court imposed a fine of $500 million on the firm (and $48 million in compensation to him), might not have faced taunts there that his action was intended to benefit his country of origin. However, going to the supreme court here in India with the same concerns, Thakur will have to contend with “nationalism” before he could save some lives.

He has filed a PIL against the health ministry, the drugs consultative committee and the Central Drugs Standard Control Organization (CDSCO), accusing them of failing to enforce drug safety rules in India, Reuters has reported.

While the case is listed for hearing on Friday, CDSCO chief GN Singh has been quoted as saying that India’s regulatory agencies respect and appreciate whistleblowers but their “intentions should be genuine, nationalistic”. On Twitter, Thakur’s response was:

Thakur was referring to the deaths of a number of women in sterlisation camps in Bilaspur of Chhattisgarh in late 2014 – due to fake medicines. Read Governance Now’s full ground report.

To appreciate Singh’s concerns, one can refer to his interview with the Business Standard soon after the US court’s Ranbaxy verdict. He had said in 2014 that if he applied the US FDA standards, he would have to shut almost all drug facilities.

Later, he told Governance Now that Ranbaxy in India had been asked to comply with all regulations.

Also read: Dirty medicine: Ranbaxy's FDA travails
 

 

Comments

 

Other News

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Who checks the books?

I read about the news about the Coimbatore library over coffee this morning. On the face of it, the headline was about a political ‘war’ between the DMK and TVK. But what stayed with me was something much more important than the blame game behind what had transpired. A writer walking through

Development paradox: Falling poverty miracle and an inequality problem

India’s reduction in poverty over the past decade is a development achievement of considerable significance. The World Bank’s April 2026 ‘India Development Update’ estimates that the share of Indians living below the international extreme-poverty line of $3.00 per person per day i

In Arunachal, a river we call mother

In Arunachal Pradesh, the Siang is not just a river. For many of us, especially the Adi people, it is part of our family. Our grandparents fished in it. Children learned to swim in it. Our farms drink from it. When someone says a huge dam will be built on it, we do not hear the word "project".

A new retelling of the Mahabharata delves into key moments

In a time when every decision carries consequences and questions of ambition, power, loyalty, identity and moral choice continue to shape our lives, Dr. Arun Krishnan’s new book, ‘Mahakshana’ (Penguin India) offers a strikingly relevant retelling of the Mahabharata.  

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter